Rutgers Institute for Translational Medicine and Science, and.
Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and.
Am J Respir Cell Mol Biol. 2022 Jan;66(1):96-106. doi: 10.1165/rcmb.2021-0345OC.
In most living cells, the second-messenger roles for adenosine 3',5'-cyclic monophosphate (cAMP) are short-lived, confined to the intracellular space, and tightly controlled by the binary switch-like actions of Gα (stimulatory G protein)-activated adenylyl cyclase (cAMP production) and cAMP-specific PDE (cAMP breakdown). Here, by using human airway smooth muscle (HASM) cells in culture as a model, we report that activation of the cell-surface βAR (β-adrenoceptor), a G-coupled GPCR (G protein-coupled receptor), evokes cAMP egress to the extracellular space. Increased extracellular cAMP levels ([cAMP]) are long-lived in culture and are induced by receptor-dependent and receptor-independent mechanisms in such a way as to define a universal response class of increased intracellular cAMP levels ([cAMP]). We find that HASM cells express multiple ATP-binding cassette (ABC) membrane transporters, with (ABC subfamily member C 1) being the most highly enriched transcript mapped to MRPs (multidrug resistance-associated proteins). We show that pharmacological inhibition or downregulation of ABCC1 with siRNA markedly reduces βAR-evoked cAMP release from HASM cells. Furthermore, inhibition of ABCC1 activity or expression decreases basal tone and increases β-agonist-induced HASM cellular relaxation. These findings identify a previously unrecognized role for ABCC1 in the homeostatic regulation of [cAMP] in HASM that may be conserved traits of the G-GPCRs (G-coupled family of GPCRs). Hence, the general features of this activation mechanism may uncover new disease-modifying targets in the treatment of airflow obstruction in asthma. Surprisingly, we find that serum cAMP levels are elevated in a small cohort of patients with asthma as compared with control subjects, which warrants further investigation.
在大多数活细胞中,腺苷 3',5'-环单磷酸(cAMP)的第二信使作用是短暂的,局限于细胞内空间,并受到 Gα(刺激性 G 蛋白)激活的腺苷酸环化酶(cAMP 产生)和 cAMP 特异性 PDE(cAMP 分解)的二进制开关样作用的严格控制。在这里,我们通过使用培养的人气道平滑肌(HASM)细胞作为模型,报告细胞表面βAR(β-肾上腺素能受体)的激活,即 G 偶联 GPCR(G 蛋白偶联受体),引发 cAMP 向细胞外空间逸出。培养物中细胞外 cAMP 水平([cAMP])的半衰期较长,并且通过受体依赖性和受体非依赖性机制诱导,从而定义了细胞内 cAMP 水平升高的通用反应类([cAMP])。我们发现 HASM 细胞表达多种 ATP 结合盒(ABC)膜转运蛋白,其中(ABC 亚家族成员 C1)是映射到多药耐药相关蛋白(MRP)的最丰富转录本。我们表明,用药理学抑制剂或 siRNA 下调 ABCC1 可显着减少 HASM 细胞中βAR 诱导的 cAMP 释放。此外,抑制 ABCC1 活性或表达降低了基础张力并增加了β-激动剂诱导的 HASM 细胞松弛。这些发现确定了 ABCC1 在 HASM 中 cAMP 稳态调节中的先前未知作用,这可能是 G-GPCR(G 偶联家族 GPCR)的保守特征。因此,这种激活机制的一般特征可能会揭示治疗哮喘气流阻塞的新的疾病修饰靶标。令人惊讶的是,我们发现与对照相比,哮喘的小队列患者的血清 cAMP 水平升高,这需要进一步研究。